Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Jaeger

Showing results (251-260 of 256) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 256 results.
Journal of Virology|June 13, 2014
Vaccine-induced HIV-1 envelope gp120 constant region 1-specific antibodies expose a CD4-inducible epitope and block the interaction of HIV-1 gp140 with galactosylceramideS Moses Dennison, Kara M Anasti, Frederick H Jaeger, et al.
European Journal of Medical Research|August 8, 2009
Treatment during primary HIV infection does not lower viral set point but improves CD4 lymphocytes in an observational cohortC Koegl, E Wolf, N Hanhoff, et al.
Cell Host & Microbe|August 15, 2014
HIV-1 envelope gp41 antibodies can originate from terminal ileum B cells that share cross-reactivity with commensal bacteriaAshley M Trama, M Anthony Moody, S Munir Alam, et al.
Journal of Virology|November 24, 2012
Antigenicity and immunogenicity of RV144 vaccine AIDSVAX clade E envelope immunogen is enhanced by a gp120 N-terminal deletionS Munir Alam, Hua-Xin Liao, Georgia D Tomaras, et al.
Immunity|December 20, 2014
Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conservedKevin Wiehe, David Easterhoff, Kan Luo, et al.
The Journal of Clinical Investigation|June 9, 2015
Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmissionSallie R Permar, Youyi Fong, Nathan Vandergrift, et al.
Pageof 26

Showing results (251-260 of 256) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 256 results.
Journal of Virology|June 13, 2014
Vaccine-induced HIV-1 envelope gp120 constant region 1-specific antibodies expose a CD4-inducible epitope and block the interaction of HIV-1 gp140 with galactosylceramideS Moses Dennison, Kara M Anasti, Frederick H Jaeger, et al.
European Journal of Medical Research|August 8, 2009
Treatment during primary HIV infection does not lower viral set point but improves CD4 lymphocytes in an observational cohortC Koegl, E Wolf, N Hanhoff, et al.
Cell Host & Microbe|August 15, 2014
HIV-1 envelope gp41 antibodies can originate from terminal ileum B cells that share cross-reactivity with commensal bacteriaAshley M Trama, M Anthony Moody, S Munir Alam, et al.
Journal of Virology|November 24, 2012
Antigenicity and immunogenicity of RV144 vaccine AIDSVAX clade E envelope immunogen is enhanced by a gp120 N-terminal deletionS Munir Alam, Hua-Xin Liao, Georgia D Tomaras, et al.
Immunity|December 20, 2014
Antibody light-chain-restricted recognition of the site of immune pressure in the RV144 HIV-1 vaccine trial is phylogenetically conservedKevin Wiehe, David Easterhoff, Kan Luo, et al.
The Journal of Clinical Investigation|June 9, 2015
Maternal HIV-1 envelope-specific antibody responses and reduced risk of perinatal transmissionSallie R Permar, Youyi Fong, Nathan Vandergrift, et al.
Pageof 26